Correlates of suicidal behavior and lithium treatment in bipolar disorderDUNNER, David L.The Journal of clinical psychiatry. Supplement. 2004, Vol 65, Num 10, pp 5-10, 6 p.Conference Paper

Acute and maintenance treatment of chronic depressionDUNNER, David L.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 6, pp 10-16Conference Paper

Drugs therapy: predictors of responseROSENBAUM, Jerrold F; DUNNER, David L.The Psychiatric clinics of North America. 2003, Vol 26, Num 2, issn 0193-953X, 225 p.Serial Issue

Pharmacogenomics of psychiatric drug treatmentPICKAR, David.The Psychiatric clinics of North America. 2003, Vol 26, Num 2, issn 0193-953X, vii, 303-321 [19 p.]Article

Predictors of response to antidepressants: General principles and clinical implicationsNIERENBERG, Andrew A.The Psychiatric clinics of North America. 2003, Vol 26, Num 2, issn 0193-953X, viii, 345-352 [8 p.]Article

Predictors of response in depressionESPOSITO, Karin; GOODNICK, Paul.The Psychiatric clinics of North America. 2003, Vol 26, Num 2, issn 0193-953X, viii, 353-365 [13 p.]Article

Treatment of schizophrenia: preventing the progression of diseaseCSERNANSKY, John G.The Psychiatric clinics of North America. 2003, Vol 26, Num 2, pp viii-ix, issn 0193-953X, 14 p.Article

Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression : Post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trialsDUNNER, David L; LIPSCHITZ, Alan; PITTS, Cornelius D et al.Clinical therapeutics. 2005, Vol 27, Num 12, pp 1901-1911, issn 0149-2918, 11 p.Article

A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorderSHELTON, Richard C; HAMAN, Kirsten L; RAPAPORT, Mark H et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 11, pp 1674-1681, issn 0160-6689, 8 p.Article

Frontal lobe gray matter density decreases in Bipolar I disorderIN KYOON LYOO; KIM, Minue J; STOLL, Andrew L et al.Biological psychiatry (1969). 2004, Vol 55, Num 6, pp 648-651, issn 0006-3223, 4 p.Article

Biological predictors of treatment response in affective illnessPERLIS, Roy H; IOSIFESCU, Dan V; RENSHAW, Perry F et al.The Psychiatric clinics of North America. 2003, Vol 26, Num 2, issn 0193-953X, vii, 323-344 [22 p.]Article

Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) studyFAVA, Maurizio; JOHN RUSH, A; KUPFER, David J et al.The Psychiatric clinics of North America. 2003, Vol 26, Num 2, issn 0193-953X, x, 457-494 [38 p.]Article

Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depressionGELENBERG, Alan J; TRIVEDI, Madhukar H; KEITNER, Gabor I et al.Biological psychiatry (1969). 2003, Vol 54, Num 8, pp 806-817, issn 0006-3223, 12 p.Article

Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combinationZAJECKA, John; DUNNER, David L; BORIAN, Frances E et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 8, pp 709-716, issn 0160-6689Article

Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT StudyGELENBERG, Alan J; DUNNER, David L; ROTHSCHILD, Anthony J et al.The Journal of nervous and mental disease. 2013, Vol 201, Num 4, pp 266-273, issn 0022-3018, 8 p.Article

Addition of atomoxetine for depression incompletely responsive to sertraline : A randomized, double-blind, placebo-controlled studyMICHELSON, David; ADLER, Lenard A; AMSTERDAM, Jay D et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 4, pp 582-587, issn 0160-6689, 6 p.Article

Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cyclingSANGER, Todd M; TOHEN, Mauricio; VIETA, Eduard et al.Journal of affective disorders. 2003, Vol 73, Num 1-2, pp 155-161, issn 0165-0327, 7 p.Article

Efficacy of controlled-release paroxetine in the treatment of late-life depressionRAPAPORT, Mark Hyman; SCHNEIDER, Lon S; DUNNER, David L et al.The Journal of clinical psychiatry. 2003, Vol 64, Num 9, pp 1065-1074, issn 0160-6689, 10 p.Article

The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depressionMANBER, Rachel; RUSH, A. John; BORIAN, Fran E et al.Sleep (New York, NY). 2003, Vol 26, Num 2, pp 130-136, issn 0161-8105, 7 p.Article

Differential effects of nefazodone and Cognitive Behavioral Analysis System of psychotherapy on insomnia associated with chronic forms of major depressionTHASE, Michael E; RUSH, A. John; BORIAN, Frances E et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 6, pp 493-500, issn 0160-6689Article

A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depressionAVERY, David H; HOLTZHEIMER, Paul E; FAWAZ, Walid et al.Biological psychiatry (1969). 2006, Vol 59, Num 2, pp 187-194, issn 0006-3223, 8 p.Article

Basal ganglia shape alterations in bipolar disorderHWANG, Jaeuk; IN KYOON LYOO; DAGER, Stephen R et al.The American journal of psychiatry. 2006, Vol 163, Num 2, pp 276-285, issn 0002-953X, 10 p.Article

Is treatment-associated hypomania rare with duloxetine : Secondary analysis of controlled trials in non-bipolar depressionDUNNER, David L; D'SOUZA, Deborah N; KAJDASZ, Daniel K et al.Journal of affective disorders. 2005, Vol 87, Num 1, pp 115-119, issn 0165-0327, 5 p.Article

Lithium and valproic acid treatment effects on brain chemistry in bipolar disorderFRIEDMAN, Seth D; DAGER, Stephen R; PAROW, Aimee et al.Biological psychiatry (1969). 2004, Vol 56, Num 5, pp 340-348, issn 0006-3223, 9 p.Article

Paroxetine controlled release. CommentariesBANG, Lynne M; KEATING, Gillian M; BEN GREEN, Y et al.CNS drugs. 2004, Vol 18, Num 6, pp 355-366, issn 1172-7047, 12 p.Article